<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H3871878BA54D44AFAB3A3919BCE2C83A" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2197 IH: No 340B Savings for Transgender Care Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2197</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250318">March 18, 2025</action-date><action-desc><sponsor name-id="J000301">Mr. Johnson of South Dakota</sponsor> (for himself, <cosponsor name-id="S001189">Mr. Austin Scott of Georgia</cosponsor>, <cosponsor name-id="C001120">Mr. Crenshaw</cosponsor>, <cosponsor name-id="R000619">Mr. Rulli</cosponsor>, <cosponsor name-id="E000235">Mr. Ezell</cosponsor>, <cosponsor name-id="B000740">Mrs. Bice</cosponsor>, <cosponsor name-id="M001212">Mr. Moore of Alabama</cosponsor>, and <cosponsor name-id="R000612">Mr. Rose</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.</official-title></form><legis-body id="H7AF0855022254E93AE54ADCE04051671" style="OLC"><section id="HD9C6E18C4A024675842656AC03F51C25" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>No 340B Savings for Transgender Care Act</short-title></quote>.</text></section><section id="H1702FE3679BF457295613EA3A9819D87"><enum>2.</enum><header>Prohibition on use of 340b savings for services described for transgender individuals</header><subsection id="H6A9C1E8081714A46985FAD226CDFA56A"><enum>(a)</enum><header>Prohibition on use of 340<enum-in-header>B</enum-in-header> savings for services described</header><text>Section 340B(a)(4) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/256b">42 U.S.C. 256b(a)(5)</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" id="H3A06D046D9034038B1F999CC0A89A22C" display-inline="no-display-inline"><subparagraph id="H3EAC06CDDFFB4E8CB3D9DD01B54ACCFD"><enum>(E)</enum><header>Prohibition on use of 340b savings for services described</header><text display-inline="yes-display-inline">A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.</text><clause id="H75CEA26718B945C586D59F46330EDAE9"><enum>(i)</enum><header>Definitions</header><text display-inline="yes-display-inline">For purposes of this subsection—</text><subclause id="H411B5365711349ADA005E7DE7B7CCA76"><enum>(I)</enum><header>Covered entity</header><text>The term <quote>covered entities</quote> has the meaning given such term in section 340B(a)(4).</text></subclause><subclause id="HFF059C24C02241BCA2D111E459F17D13"><enum>(II)</enum><header>Services described</header><text display-inline="yes-display-inline">The term <quote>services described</quote> means—</text><item id="HBEB4273045654708982FCD60FF340088"><enum>(aa)</enum><text>sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and</text></item><item id="HDFC8072441CC4606B82376E927084B8C"><enum>(bb)</enum><text>hormone treatments furnished for the purpose of the gender alteration of a transgender individual.</text></item></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section></legis-body></bill> 

